The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Identification of small molecules that interfere with c-di-GMP signaling and induce dispersal of Pseudomonas aeruginosa biofilms
Abstract
Microbial biofilms are involved in a number of infections that cannot be cured, as microbes in biofilms resist host immune defenses and antibiotic therapies. With no strict biofilm-antibiotic in the current pipelines, there is an unmet need for drug candidates that enable the current antibiotics to eradicate bacteria in biofilms. We used high-throughput screening to identify chemical compounds that reduce the intracellular c-di-GMP content in Pseudomonas aeruginosa. This led to the identification of a small molecule that efficiently depletes P. aeruginosa for c-di-GMP, inhibits biofilm formation, and disperses established biofilm. A combination of our lead compound with standard of care antibiotics showed improved eradication of an implant-associated infection established in mice. Genetic analyses provided evidence that the anti-biofilm compound stimulates the activity of the c-di-GMP phosphodiesterase BifA in P. aeruginosa. Our work constitutes a proof of concept for c-di-GMP phosphodiesterase-activating drugs administered in combination with antibiotics as a viable treatment strategy for otherwise recalcitrant infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In P. aeruginosa, it reduced c-di-GMP, prevented biofilm formation, and dispersed established biofilms.”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [188]
In the citing paper
“An analog, H6-335-P1, activated the BifA PDE and, when combined with antibiotics, cleared implant-associated infections in mice [188,189].”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [188]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dessauer, C. W., Watts, V. J., Ostrom, R. S., Conti, M., Dove, S., & Seifert, R. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013078 · Cited by 201
Self-citation
Research works printed but not linked: 72
- Costerton, J. W., Stewart, P. S. & Greenberg, E. P. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318–1322 (1999). · DOI · Paper page
- Ciofu, O. & Tolker-Nielsen, T. Tolerance and resistance of pseudomonas aeruginosa biofilms to antimicrobial agents-how p. aeruginosa can escape antibiotics. Front. Microbiol. 10, 913 (2019). · DOI · Paper page
- Tolker-Nielsen, T. Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities. APMIS Suppl., 1-51, (2014). · DOI
- Bryers, J. D. Medical biofilms. Biotechnol. Bioeng. 100, 1–18 (2008). · DOI · Paper page
- Bjarnsholt, T. The role of bacterial biofilms in chronic infections. APMIS Supp.l, 1-51, (2013). · DOI · Paper page
- Rasmussen, T. B. et al. Identity and effects of quorum-sensing inhibitors produced by Penicillium species. Microbiology 151, 1325–1340 (2005). · DOI · Paper page
- Jenal, U., Reinders, A. & Lori, C. Cyclic di-GMP: second messenger extraordinaire. Nat. Rev. Microbiol. 15, 271–284 (2017). · DOI · Paper page
- Christensen, L. D. et al. Clearance of Pseudomonas aeruginosa foreign-body biofilm infections through reduction of the cyclic Di-GMP level in the bacteria. Infect. Immun. 81, 2705–2713 (2013). · DOI
- Gjermansen, M., Ragas, P. & Tolker-Nielsen, T. Proteins with GGDEF and EAL domains regulate Pseudomonas putida biofilm formation and dispersal. FEMS Microbiol. Lett. 265, 215–224 (2006). · DOI
- Gjermansen, M., Nilsson, M., Yang, L. & Tolker-Nielsen, T. Characterization of starvation-induced dispersion in Pseudomonas putida biofilms: genetic elements and molecular mechanisms. Mol. Microbiol. 75, 815–826 (2010). · DOI · Paper page
- Andersen, J. B. et al. Induction of native c-di-GMP phosphodiesterases leads to dispersal of Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother., https://doi.org/10.1128/AAC.02431-20 (2021). · DOI
- Wood, T. K., Hong, S. H. & Ma, Q. Engineering biofilm formation and dispersal. Trends Biotechnol. 29, 87–94 (2011). · DOI
- Opoku-Temeng, C., Zhou, J., Zheng, Y., Su, J. & Sintim, H. O. Cyclic dinucleotide (c-di-GMP, c-di-AMP, and cGAMP) signalings have come of age to be inhibited by small molecules. Chem. Commun. (Camb.) 52, 9327–9342 (2016). · DOI
- Jakobsen, T. H., Tolker-Nielsen, T. & Givskov, M. Bacterial biofilm control by perturbation of bacterial signaling processes. Int. J. Mol. Sci. 18, https://doi.org/10.3390/ijms18091970 (2017). · DOI
- Antoniani, D. et al. The immunosuppressive drug azathioprine inhibits biosynthesis of the bacterial signal molecule cyclic-di-GMP by interfering with intracellular nucleotide pool availability. Appl. Microbiol. Biotechnol. 97, 7325–7336 (2013). · DOI
- Hee, C. S. et al. Intercepting second-messenger signaling by rationally designed peptides sequestering c-di-GMP. Proc. Natl Acad. Sci. USA 117, 17211–17220 (2020). · DOI
- Qvortrup, K. et al. Small molecule anti-biofilm agents developed on the basis of mechanistic understanding of biofilm formation. Front. Chem. 7, 742 (2019). · DOI
- Zhou, J. et al. Potent suppression of c-di-GMP synthesis via I-site allosteric inhibition of diguanylate cyclases with 2’-F-c-di-GMP. Bioorg. Med. Chem. 21, 4396–4404 (2013). · doi:10.1016/j.bmc.2013.04.050
- Ching, S. M., Tan, W. J., Chua, K. L. & Lam, Y. Synthesis of cyclic di-nucleotidic acids as potential inhibitors targeting diguanylate cyclase. Bioorg. Med. Chem. 18, 6657–6665 (2010). · doi:10.1016/j.bmc.2010.07.068
- Fernicola, S. et al. Synthesis of triazole-linked analogues of c-di-GMP and their interactions with diguanylate cyclase. J. Med. Chem. 58, 8269–8284 (2015). · doi:10.1021/acs.jmedchem.5b01184
- Fernicola, S. et al. In silico discovery and in vitro validation of catechol-containing sulfonohydrazide compounds as potent inhibitors of the diguanylate cyclase PleD. J. Bacteriol. 198, 147–156 (2016). · DOI
- Sambanthamoorthy, K. et al. Identification of small molecules inhibiting diguanylate cyclases to control bacterial biofilm development. Biofouling 30, 17–28 (2014). · DOI
- Lieberman, O. J., Orr, M. W., Wang, Y. & Lee, V. T. High-throughput screening using the differential radial capillary action of ligand assay identifies ebselen as an inhibitor of diguanylate cyclases. ACS Chem. Biol. 9, 183–192 (2014). · DOI
- Christen, M. et al. Identification of small-molecule modulators of diguanylate cyclase by FRET-based high-throughput screening. Chembiochem 20, 394–407 (2019). · DOI
- Zheng, Y., Tsuji, G., Opoku-Temeng, C. & Sintim, H. O. Inhibition of P. aeruginosa c-di-GMP phosphodiesterase RocR and swarming motility by a benzoisothiazolinone derivative. Chem. Sci. 7, 6238–6244 (2016). · DOI
- Sambanthamoorthy, K. et al. Identification of small molecules that antagonize diguanylate cyclase enzymes to inhibit biofilm formation. Antimicrob. Agents Chemother. 56, 5202–5211 (2012). · DOI · Paper page
- Groizeleau, J. et al. The anti-cancerous drug doxorubicin decreases the c-di-GMP content in Pseudomonas aeruginosa but promotes biofilm formation. Microbiology 162, 1797–1807 (2016). · DOI
- van Tilburg Bernardes, E., Charron-Mazenod, L., Reading, D. J., Reckseidler-Zenteno, S. L. & Lewenza, S. Exopolysaccharide-repressing small molecules with antibiofilm and antivirulence activity against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 61, https://doi.org/10.1128/AAC.01997-16 (2017). · DOI
- Barraud, N. et al. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J. Bacteriol. 188, 7344–7353 (2006). · DOI · Paper page
- Barraud, N. et al. Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J. Bacteriol. 191, 7333–7342 (2009). · DOI · Paper page
- Cai, Y. M. et al. Differential impact on motility and biofilm dispersal of closely related phosphodiesterases in Pseudomonas aeruginosa. Sci. Rep. 10, 6232 (2020). · DOI
- Rybtke, M. T. et al. Fluorescence-based reporter for gauging cyclic di-GMP levels in Pseudomonas aeruginosa. Appl. Environ. Microbiol. 78, 5060–5069 (2012). · DOI · Paper page
- Sarenko, O. et al. More than enzymes that make or break cyclic di-GMP-local signaling in the interactome of GGDEF/EAL domain proteins of Escherichia coli. MBio 8, https://doi.org/10.1128/mBio.01639-17 (2017). · DOI
- Friedman, L. & Kolter, R. Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms. Mol. Microbiol. 51, 675–690 (2003). · DOI · Paper page
- Kuchma, S. L. et al. BifA, a cyclic-Di-GMP phosphodiesterase, inversely regulates biofilm formation and swarming motility by Pseudomonas aeruginosa PA14. J. Bacteriol. 189, 8165–8178 (2007). · DOI · Paper page
- Held, K., Ramage, E., Jacobs, M., Gallagher, L. & Manoil, C. Sequence-verified two-allele transposon mutant library for Pseudomonas aeruginosa PAO1. J. Bacteriol. 194, 6387–6389 (2012). · doi:10.1128/jb.01479-12
- Serra, D. O., Richter, A. M. & Hengge, R. Cellulose as an architectural element in spatially structured Escherichia coli biofilms. J. Bacteriol. 195, 5540–5554 (2013). · DOI · Paper page
- Romling, U., Gomelsky, M. & Galperin, M. Y. C-di-GMP: the dawning of a novel bacterial signalling system. Mol. Microbiol. 57, 629–639 (2005). · DOI · Paper page
- Hickman, J. W., Tifrea, D. F. & Harwood, C. S. A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels. Proc. Natl. Acad. Sci. USA 102, 14422–14427 (2005). · DOI · Paper page
- Starkey, M. et al. Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung. J. Bacteriol. 191, 3492–3503 (2009). · DOI · Paper page
- Bernard, C. S., Bordi, C., Termine, E., Filloux, A. & de Bentzmann, S. Organization and PprB-dependent control of the Pseudomonas aeruginosa tad Locus, involved in Flp pilus biology. J. Bacteriol. 191, 1961–1973 (2009). · DOI
- Vance, R. E., Hong, S., Gronert, K., Serhan, C. N. & Mekalanos, J. J. The opportunistic pathogen Pseudomonas aeruginosa carries a secretable arachidonate 15-lipoxygenase. Proc. Natl Acad. Sci. USA 101, 2135–2139 (2004). · DOI · Paper page
- Deschamps, J. D. et al. Biochemical and Cellular Characterization and Inhibitor Discovery of Pseudomonas aeruginosa 15-Lipoxygenase. Biochemistry 55, 3329–3340 (2016). · DOI
- Morello, E. et al. Pseudomonas aeruginosa lipoxygenase LoxA contributes to lung infection by altering the host immune lipid signaling. Front. Microbiol. 10, 1826 (2019). · DOI
- Kamal, A. et al. Design and synthesis of pyrazole-oxindole conjugates targeting tubulin polymerization as new anticancer agents. Eur. J. Med. Chem. 92, 501–513 (2015). · doi:10.1016/j.ejmech.2013.10.077
- Yamamoto, S. et al. Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonists. Bioorg. Med. Chem. 20, 2338–2352 (2012). · DOI
- Fouda, A. M. et al. Synthesis, in vitro antimicrobial and cytotoxic activities of some new pyrazolo[1,5-a]pyrimidine derivatives. Molecules 24, https://doi.org/10.3390/molecules24061080 (2019). · doi:10.3390/molecules24061080
- Viveka, S. et al. Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents. Eur. J. Med. Chem. 101, 442–451 (2015). · doi:10.1016/j.ejmech.2015.07.002
- Mizuhara, T. et al. Structure-activity relationship study of phenylpyrazole derivatives as a novel class of anti-HIV agents. Bioorg. Med. Chem. Lett. 23, 4557–4561 (2013). · DOI
- Tantawy, A. S., Nasr, M. N. A., El-Sayed, M. A. A. & Tawfik, S. S. Synthesis and antiviral activity of new 3-methyl-1,5-diphenyl-1H-pyrazole derivatives. Med. Chem. Res. 21, 4139–4149 (2011). · doi:10.1007/s00044-011-9960-2
- Yoshida, T. et al. Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-y lcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorg. Med. Chem. 20, 5705–5719 (2012). · DOI
- Bhatt, J. D., Chudasama, C. J. & Patel, K. D. Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study. Bioorg. Med. Chem. 23, 7711–7716 (2015). · doi:10.1016/j.bmc.2015.11.018
- Mahfuz Alam, M. S. Z., Alam, M. M., Arora, Karun, Ahmad, Aftab & Husain, Asif Synthesis and antimicrobial activities of new pyrazolo- pyridazine derivatives. Int. J. Pharma. Sci. Res. 6, 495–501 (2015).
- Krystof, V. et al. 4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects. J. Med. Chem. 49, 6500–6509 (2006). · DOI · Paper page
- Jorda, R. et al. Novel arylazopyrazole inhibitors of cyclin-dependent kinases. Bioorg. Med. Chem. 23, 1975–1981 (2015). · DOI
- Seifert, R. Basic Knowledge of Pharmacology (Springer, 2019). · DOI
- Sandner, P., Becker-Pelster, E. M. & Stasch, J. P. Discovery and development of sGC stimulators for the treatment of pulmonary hypertension and rare diseases. Nitric Oxide 77, 88–95 (2018). · DOI
- Xiao, S. et al. Soluble guanylate cyclase stimulators and activators: where are we and where to go? Mini Rev. Med. Chem. 19, 1544–1557 (2019). · DOI
- Alt, A. Overview of critical parameters for the design and execution of a high-throughput screen for allosteric ligands. Curr. Protoc. Pharm. 74, 9 20 21–29 20 23 (2016). · DOI
- Chambers, J. R., Cherny, K. E. & Sauer, K. Susceptibility of Pseudomonas aeruginosa dispersed cells to antimicrobial agents is dependent on the dispersion cue and class of the antimicrobial agent used. Antimicrob. Agents Chemother. 61, https://doi.org/10.1128/AAC.00846-17 (2017). · DOI · Paper page
- Cherny, K. E. & Sauer, K. Untethering and degradation of the polysaccharide matrix are essential steps in the dispersion response of Pseudomonas aeruginosa biofilms. J. Bacteriol. 202, https://doi.org/10.1128/JB.00575-19 (2020). · DOI
- Rumbaugh, K. P. & Sauer, K. Biofilm dispersion. Nat. Rev. Microbiol. 18, 571–586 (2020). · DOI · Paper page
- Lin Chua, S. et al. Reduced intracellular c-di-GMP content increases expression of quorum sensing-regulated genes in Pseudomonas aeruginosa. Front. Cell Infect. Microbiol. 7, 451 (2017). · DOI
- Massie, J. P. et al. Quantification of high-specificity cyclic diguanylate signaling. Proc. Natl. Acad. Sci. USA 109, 12746–12751 (2012). · DOI
- Pamp, S. J. & Tolker-Nielsen, T. Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa. J. Bacteriol. 189, 2531–2539 (2007). · DOI · Paper page
- An, S., Wu, J. & Zhang, L. H. Modulation of Pseudomonas aeruginosa biofilm dispersal by a cyclic-Di-GMP phosphodiesterase with a putative hypoxia-sensing domain. Appl. Environ. Microbiol. 76, 8160–8173 (2010). · DOI · Paper page
- Hoang, T. T., Kutchma, A. J., Becher, A. & Schweizer, H. P. Integration-proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains. Plasmid 43, 59–72 (2000). · DOI · Paper page
- Kovach, M. E. et al. Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166, 175–176 (1995). · DOI · Paper page
- Kulasekara, H. D. Transposon mutagenesis. Methods Mol. Biol. 1149, 501–519 (2014). · doi:10.1007/978-1-4939-0473-0_39
- Crusz, S. A. et al. Bursting the bubble on bacterial biofilms: a flow cell methodology. Biofouling 28, 835–842 (2012). · DOI
- Christensen, L. D. et al. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model. J. Antimicrob. Chemother. 67, 1198–1206 (2012). · DOI · Paper page
- Christensen, L. D. et al. Impact of Pseudomonas aeruginosa quorum sensing on biofilm persistence in an in vivo intraperitoneal foreign-body infection model. Microbiology 153, 2312–2320 (2007). · DOI
Cited by
Elbehiry, A., Marzouk, E., Edrees, H. M., Ibrahem, M., Alzahrani, S., Anagreyyah, S., Abualola, H., Alghamdi, A., Alzahrani, A., Jaber, M., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14010109 · Cited by 34
Metadata
- Authors
- Andersen, J. B., Hultqvist, L. D., Jansen, C. U., Jakobsen, T. H., Nilsson, M., Rybtke, M., Uhd, J., Fritz, B. G., Seifert, R., Berthelsen, J., Nielsen, T. E., Qvortrup, K., Givskov, M., & Tolker-Nielsen, T.
- ORCID
- Venue
- npj Biofilms and Microbiomes
- Published
- 2021-07-09
- Volume
- 7
- Issue
- 1
- ISSN
- 2055-5008
- Cited by
- 77
- References
- 1
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- Det Frie Forskningsråd
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of small molecules that interfere with c-di-GMP signaling and induce dispersal of Pseudomonas aeruginosa biofilms. https://app.cochat.ai/papers/10.1038/s41522-021-00225-4
- The paper
- Andersen, J. B., Hultqvist, L. D., Jansen, C. U., Jakobsen, T. H., Nilsson, M., Rybtke, M., Uhd, J., Fritz, B. G., Seifert, R., Berthelsen, J., Nielsen, T. E., Qvortrup, K., Givskov, M., & Tolker-Nielsen, T. (2021). Identification of small molecules that interfere with c-di-GMP signaling and induce dispersal of Pseudomonas aeruginosa biofilms. npj Biofilms and Microbiomes. https://doi.org/10.1038/s41522-021-00225-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.